sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Acute Lung Injury Market...

欧洲急性肺损伤市场预测至 2028 年 - COVID-19 影响和按治疗（机械通气、液体管理、药物治疗和辅助手术）和最终用户（医院、门诊手术中心等）进行的区域分析

TIPRE00025719 | Pages: 102 | Pharmaceuticals | Nov 2021 | Type: Regional | Status: Published

市场介绍

欧洲急性肺损伤市场分为德国、英国、法国、意大利、西班牙以及欧洲其他地区。德国在 2021 年引领市场。德国在医疗保健行业方面遥遥领先。它拥有来自世界各地的市场领导者。此外，全国各地都有知名企业为整个医疗保健行业做出贡献，包括急性肺损伤的诊断和治疗。电子烟的使用与多种肺损伤模式相关，随着这些产品的使用不断增加，这些模式最近才得到证实。例如，根据国家生物技术信息中心的数据，自2001年以来，德国14至17岁青少年的传统吸烟率有所下降。可以观察到电子烟消费的相反趋势。 “聚灵”等趋势正在兴起。越来越受到青少年的关注。受欢迎程度体现在数字上：目前，德国14-17岁的年轻人中有20.2%使用过电子烟。尽管人们认为接触电子烟潜在有害成分的风险明显低于可燃香烟，但在青春期和成年早期接触电子烟气溶胶并非没有风险，并可能导致肺毒性。同样，根据国家生物技术信息中心的数据，德国电子烟的使用率为 11.8%。呼吸系统疾病的日益流行和市场参与者的技术进步是推动欧洲急性肺损伤市场增长的主要因素。

就 COVID-19 而言，西班牙、意大利、德国、法国和英国是受影响最严重的欧洲国家之一。根据 Worldometer，截至 2021 年 9 月 16 日，西班牙、英国、意大利、德国和法国的记录为 4,922,249； 7,312,683； 4,618,040； 4,117,263；和 6,926,604 例 COVID-19 病例，这些国家的死亡人数也很高。此外，新型冠状病毒相关疾病 (COVID-19) 于 2020 年 1 月 31 日在西班牙首次发现，随后在 3 个月内发现了超过 204 178 例病例。1 严重的 COVID-19 与炎症细胞因子的高循环水平有关，例如细胞因子释放综合征，经常导致呼吸衰竭。迄今为止，感染患者的组织病理学信息很少。对组织病理学结果的描述很少，主要报道了肺炎和弥漫性肺泡损伤 (DAD)。2–5 推进对 COVID-19 相关组织损伤的了解对于了解 SARS-COV-2 造成的损伤机制非常重要。

市场概况和动态

欧洲急性肺损伤市场预计将从 2021 年的 1.5655 亿美元增长到美国到 2028 年将达到 2.1112 亿美元；预计2021年至2028年复合年增长率为4.4%。随着年龄的增长，各种细胞或组织的退化导致多种疾病的风险增加。老年人更容易受到肺、心脏和肾脏等器官衰竭的影响。这主要是由于衰老的人体生态系统的组成和代谢活动发生了变化。随着年龄的增长，器官系统的发病率降低，从而容易发生呼吸道疾病和其他感染等疾病，从而带动了目标市场的发展。因此，ALI 与老龄化人口中发病率和死亡率的增加相关。此外，年龄通常被认为是 ARDS 发生的危险因素。与英国、法国和德国等发达国家一样，发展中国家的老年人口也正在显着增长。人口老龄化；到 2050 年，65 岁以上人口预计将占总人口的六分之一，到 2019 年将增加到十分之一。老龄化与疾病发病率增加之间存在密切关系——包括慢性阻塞性肺病和急性感染等呼吸系统疾病——彻底的研究为了有效管理日益老龄化的人口的健康，有必要了解疾病风险和严重程度的影响。这些国家老年人口的增长得益于医疗保健设施的改善和医疗保健服务的改善，从而延长了预期寿命。因此，人口老龄化是欧洲急性肺损伤市场增长的主要因素之一。

关键细分市场

在治疗方面，机械通气细分市场在2020年欧洲急性肺损伤市场中占据最大份额。在最终用户方面，医院细分市场在2020年欧洲急性肺损伤市场中占有较大的市场份额.   

主要来源和上市公司

准备本文件时参考的一些主要一手和二手来源关于欧洲急性肺损伤市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Apeiron Biologics AG； APEPTICO 研究与开发有限公司；葛兰素史克公司；组织细胞； Stemedica 细胞技术公司；和 Windtree Therapeutics, Inc。

购买报告的理由

  • 了解欧洲急性肺损伤市场格局，并确定最有可能保证强劲回报的细分市场
  • 通过了解不断变化的趋势，保持领先地位-欧洲急性肺损伤市场不断变化的竞争格局
  • 通过确定最有前景的细分市场，有效规划欧洲急性肺损伤市场的并购和合作交易
  • 帮助采取通过对欧洲急性肺损伤市场各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策
  • 获取欧洲地区 2021-2028 年各个细分市场的市场收入预测。

欧洲急性肺损伤市场细分

欧洲急性肺损伤市场- 通过治疗

  • 机械通气
  • 液体管理
  • 药物治疗
  • 辅助程序

欧洲急性肺损伤市场 - 最终用户

  • 医院
  • 门诊手术中心
  • 其他

欧洲急性肺损伤市场 - 按国家

  • 英国
  • 德国
  • 法国   
  • 意大利
  • 西班牙
  • 欧洲其他地区

欧洲急性肺病损伤市场 - 公司简介

  • Apeiron Biologics AG
  • APEPTICO Forschung und Entwicklung GmbH
  • GlaxoSmithKline Plc
    • >
  • Histocell
  • Stemedica Cell Technologies, Inc.
  • Windtree Therapeutics, Inc.

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Acute Lung Injury Market – By Therapy

1.3.2        Europe Acute Lung Injury Market – By End User

1.3.3        Europe Acute Lung Injury Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Acute Lung Injury Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Acute Lung Injury Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Respiratory Diseases

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Overpriced Therapies

5.3         Market Opportunities

5.3.1        Surging Technological Advancements by Market Players

5.4         Future Trends

5.4.1        Escalating Pipeline Drugs

5.5         Impact Analysis

6.           Acute Lung Injury Market– Europe Analysis

6.1         Europe Acute Lung Injury Market Revenue Forecast and Analysis

7.           Europe Acute Lung Injury Market Analysis – By Therapy

7.1         Overview

7.2         Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

7.3         Mechanical Ventilation

7.3.1        Overview

7.3.2        Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Fluid Management

7.4.1        Overview

7.4.2        Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Pharmacotherapy

7.5.1        Overview

7.5.2        Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Adjunctive Procedures

7.6.1        Overview

7.6.2        Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Acute Lung Injury Market Analysis – By End User

8.1         Overview

8.2         Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Ambulatory Surgery Centers

8.4.1        Overview

8.4.2        Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Acute Lung Injury Market – Country Analysis

9.1         Europe: Acute Lung Injury Market

9.1.1        Overview

9.1.2        Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)

9.1.2.1          Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1          Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2          Germany: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.1.3          Germany: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.2          France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1          France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2          France: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.2.3          France: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.3          UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1          UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2          UK: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.3.3          UK: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.4          Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1          Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2          Italy: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.4.3          Italy: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.5          Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1          Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.2          Spain: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.5.3          Spain: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.6          Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1          Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.2          Rest of Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.6.3          Rest of Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on Europe Acute Lung Injury Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      GlaxoSmithKline Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Stemedica Cell Technologies, Inc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Histocell

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      APEPTICO Forschung und Entwicklung GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Windtree Therapeutics, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Apeiron Biologics AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Germany: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             France: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 5.             France: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             UK: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 7.             UK: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             Italy: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 9.             Italy: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Spain: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 11.          Spain: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Acute Lung Injury Market Segmentation

Figure 2.           Europe Acute Lung Injury Market Segmentation, By Country

Figure 3.           Europe Acute Lung Injury Market Overview

Figure 4.           Mechanical Ventilation Segment Held the Largest Share of the Market in 2021

Figure 5.           The UK to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Europe Acute Lung Injury Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Acute Lung Injury Market– Revenue Forecast and Analysis

Figure 9.           Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

Figure 10.        Europe Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Europe Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

Figure 15.        Europe Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

Figure 19.        Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

Figure 20.        Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 21.        France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 22.        UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 23.        Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in European Country Markets

  1. Apeiron Biologics AG
  2. APEPTICO Forschung und Entwicklung GmbH
  3. GlaxoSmithKline Plc
  4. Histocell
  5. Stemedica Cell Technologies, Inc
  6. Windtree Therapeutics, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe acute lung injury market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe acute lung injury market, thereby allowing players across the value chain to develop effective long-term strategies    
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the acute lung injury market, as well as those hindering it  
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription